ESSEX INVESTMENT MANAGEMENT CO LLC

Position in LGND — Ligand Pharmaceuticals Inc

CIK 201772 BOSTON, MA

Position in LGND

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$11,671,539

+$323,558 QoQ

Shares Held

58,460

-2.6% QoQ

Ownership

0.292%

of shares outstanding

% of Portfolio

1.85%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 74.86999657885734.ToString("F0")% Shared 0.ToString("F0")% None 25.13000342114266.ToString("F0")%

Healthcare · as of Mar 31, 2026

ESSEX INVESTMENT MANAGEMENT CO LLC holds $60,210,603 across 12 Biotechnology names. LGND ranks #1 (19.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LGND	Ligand Pharmaceuticals Inc This page	58,460	$11,671,539
2	INSM	INSMED Inc	62,676	$10,248,779
3	MIRM	Mirum Pharmaceuticals, Inc.	108,338	$10,008,264
4	TVTX	Travere Therapeutics, Inc.	161,705	$4,804,255
5	SNDX	Syndax Pharmaceuticals Inc	198,985	$4,648,289
6	JAZZ	Jazz Pharmaceuticals plc	21,778	$4,117,130
7	AGIO	Agios Pharmaceuticals, Inc.	103,177	$3,490,477
8	ARQT	Arcutis Biotherapeutics, Inc.	143,934	$3,391,085

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$11,671,539	58,460	-2.6%	Shares	Sole	2026-05-11
2025-12-31	$11,347,981	60,020	-1.8%	Shares	Sole	2026-02-13
2025-09-30	$10,830,693	61,142	+0.5%	Shares	Sole	2025-11-06
2025-06-30	$6,912,880	60,810	-1.4%	Shares	Sole	2025-08-12
2025-03-31	$6,487,348	61,702	-5.4%	Shares	Sole	2025-05-07
2024-12-31	$6,991,216	65,247	-5.6%	Shares	Sole	2025-02-07
2024-09-30	$6,921,023	69,148	-2.3%	Shares	Sole	2024-10-10
2024-06-30	$5,963,922	70,780	—	Shares	Sole	2024-08-12
No filing history on record for this holder in this stock.